Pall follows Thermo Fisher, Sartorius trend for single-use tech
Pall has completed its acquisition of ATMI LifeSciences, making it the latest firm to strengthen its single-use bioreactor portfolio.
Pall has completed its acquisition of ATMI LifeSciences, making it the latest firm to strengthen its single-use bioreactor portfolio.
Tokyo, Japan-based JCR Pharmaceuticals has asked UK firm Plasticell to help develop differentiation protocols for its range of candidate stem cell-based therapies.
Watson-Marlow Pumps Group (WMPG) has bought single-use connection technology developer Bio Pure Technology in a deal designed to bolster its biopharmaceutical manufacturing portfolio.